Are we selecting the right model compounds for advanced formulation research?
Authors:
- Tamás SolymosiTamás Solymosi
- Dalip KumarDKDalip Kumar
- Jesús Alberto Afonso UrichJUJesús Alberto Afonso Urich
- Theresa Hörmann-KincsesTHTheresa Hörmann-Kincses
- Martin SpoerkMSMartin Spoerk
- Johannes KhinastJKJohannes Khinast
- 10 October 2026
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
Abstract
No abstract availableThis publication has 108 references indexed in Scilit:
- Intestinal absorption pathways of lisinopril: Mechanistic investigationsBiopharmaceutics & Drug Disposition, 2022
- Evaluation of a Nanoemulsion Formulation Strategy for Oral Bioavailability Enhancement of Danazol in Rats and DogsJournal of Pharmaceutical Sciences, 2013
- Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: KetoprofenJournal of Pharmaceutical Sciences, 2012
- The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation DevelopmentJournal of Pharmaceutical Sciences, 2010
- Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol)Journal of Pharmaceutical Sciences, 2006
- Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast & Zocor) in healthy human volunteersBiopharmaceutics & Drug Disposition, 2003
- Dose dependent pharmacokinetics of albendazole in humanBiopharmaceutics & Drug Disposition, 2002
- Development and in vivo evaluation of buccal tablets prepared using danazol–sulfobutylether 7 β‐cyclodextrin (SBE 7) complexesJournal of Pharmaceutical Sciences, 2002
- Effect of Food and a Monoglyceride Emulsion Formulation on Danazol BioavailabilityThe Journal of Clinical Pharmacology, 1993
- Absorption Kinetics of Griseofulvin in ManJournal of Pharmaceutical Sciences, 1968